Summary
Elevance Health, Inc. (formerly Anthem, Inc.) filed an 8-K on September 8, 2021, to provide updated financial guidance. The company reaffirmed its net income guidance for the full year 2021, projecting it to be greater than $24.89 per share, which includes approximately $0.61 per share of net unfavorable items. Excluding these specific items, Elevance Health anticipates its adjusted net income to exceed $25.50 per share. This communication is primarily for informational purposes, reiterating previously disclosed expectations and does not include any new adjustments beyond those reported in the second quarter 2021 earnings release. Investors should note that this filing contains forward-looking statements and is subject to various risks and uncertainties that could cause actual results to differ materially from projections. The company urges a review of its SEC filings for a comprehensive understanding of these potential risks.
Key Highlights
- 1Reaffirmed full-year 2021 net income guidance: greater than $24.89 per share.
- 2Full-year 2021 guidance includes approximately $0.61 per share in net unfavorable items.
- 3Expects adjusted net income for full-year 2021 to be greater than $25.50 per share.
- 4Guidance does not incorporate any new adjustment items beyond those from Q2 2021 earnings.
- 5The information was shared during investor meetings over the coming weeks.
- 6The filing contains forward-looking statements subject to significant risks and uncertainties.
- 7Investors are cautioned to review the company's SEC filings for detailed risk factors.